Martingale Asset Management L P Biocryst Pharmaceuticals Inc Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$4.13 - $6.79 $39,449 - $64,858
9,552 Added 21.46%
54,055 $334,000
Q1 2024

May 14, 2024
BUY
$4.89 - $7.65 $139,198 - $217,764
28,466 Added 177.5%
44,503 $226,000
Q4 2023

Feb 12, 2024
BUY
$4.98 - $6.77 $79,864 - $108,570
16,037 New
16,037 $96,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email